Angany (Canada) and Phylloceuticals (USA): two biotechnology innovators team up to accelerate Covid NAbs commercialization

QUEBEC CITY and AUSTIN, Texas, March 24, 2021 /CNW Telbec/ - Dr Louis-Philippe Vézina CEO of Angany, and Mr. Bill Brydges, CEO of Phylloceuticals announce today that the two companies will team up to accelerate the development of a preventive and curative product based on neutralizing monoclonal antibodies (NAbs) against SARS CoV-02 and its variants.

NewsGuest UserMarch 24, 2021Angany, COVID-19, Antibodies